Douglas Gladstone, M.D.
Medical Oncology Physician in Baltimore, Maryland.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Douglas Gladstone, M.D. reported a CMS MIPS final score of 74.1/100 - below the 83.5 national average - and filed 434 Medicare Part D claims in 2024.
- 74.1/100
- MIPS score · -9 vs avg
- 434
- Part D claims, 2024
- 56%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Douglas Gladstone, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1386660207), first enumerated 07/14/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 434 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 74.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$5.3K in reported industry payments (11 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1386660207 · Medical Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1386660207
- ENUM-LEGACY 2006
- TAX-NARROW 4,028
- MIPS-BELOW 74.1/100
- RX-LIGHT 434
- BOOK-THIN 186 in Maryland
- PHOTO-FINISH Francisco Esteva · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Gladstone · this…
Gladstone · this provider
74.1 MIPS pts
- Marisa Siebel · …
Marisa Siebel
74.1 MIPS pts
- Francisco Esteva…
Francisco Esteva
74.1 MIPS pts
- Elena Katz · near
Elena Katz
74.1 MIPS pts
- Maria Nieto · near
Maria Nieto
74.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Douglas Gladstone, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
74 ≥ 13th percentile 13% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Douglas Gladstone, M.D. sits
This provider among medical oncology physician peers
Across the 1,398 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Douglas Gladstone, M.D. writes more Part D claims than 49% of them and scores higher on MIPS quality than 6% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Douglas Gladstone, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Douglas Gladstone, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Douglas Gladstone, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Maryland
How Medical Oncology Physician compares to other specialties among Maryland providers
Medical Oncology Physician ranks #92 among Maryland's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Maryland provider total, by primary NUCC taxonomy. The highlighted bar is Medical Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Douglas Gladstone, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 74.1/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Medical Oncology Physician US NPIs
74.1/100 MIPS final score - 9.4 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical Oncology Physician. Quality dim: 60.2. Cost dim: 56.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1386660207 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/14/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Douglas Gladstone, M.D.'s current license status, disciplinary history, and board certifications with the Maryland Board of Physicians in Maryland before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1386660207 is the unique 10-digit identifier CMS uses to link Gladstone across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Douglas Gladstone, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Douglas Gladstone, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$5.3K
Largest payer
Adaptive Biotechnologies Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
44% brand-name claims vs 56% generic, on 434 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 444
- Total Day Supply
- 11,873
- Brand vs Generic
- 44% brand / 56% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $7K
- Antibiotic Claims
- 44
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 2.16
- Gender Split
- 54% female / 46% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Douglas Gladstone, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Calquence
Calquence
55 claims
- Sulfamethoxazole-T…
Sulfamethoxazole-Trimethoprim
36 claims
- Venclexta
Venclexta
31 claims
- Mirtazapine
Mirtazapine
24 claims
- Duloxetine Hcl 21
Duloxetine Hcl
21 claims
- Brukinsa 20
Brukinsa
20 claims
- Prednisone 18
Prednisone
18 claims
- Privigen 16
Privigen
16 claims
| Drug | Claims |
|---|---|
| Calquence Acalabrutinib Maleate | 55 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 36 |
| Venclexta Venetoclax | 31 |
| Mirtazapine | 24 |
| Duloxetine Hcl | 21 |
| Brukinsa Zanubrutinib | 20 |
| Prednisone | 18 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 16 |
| Gemtesa Vibegron | 13 |
| Valacyclovir Valacyclovir Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Douglas Gladstone, M.D. fits within the Medical Oncology Physician landscape nationally.
Douglas Gladstone, M.D.'s 434 claims are below the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gladstone, both outside Maryland so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (74.1 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Gladstone.
One of 186 Medical Oncology Physician providers enrolled in Maryland, 5 are shown here.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Douglas Gladstone, M.D.'s specialty? ▼
How much does Douglas Gladstone, M.D. prescribe under Medicare Part D? ▼
What is Douglas Gladstone, M.D.'s Medicare quality score? ▼
Where is Douglas Gladstone, M.D. located? ▼
What is Douglas Gladstone, M.D.'s NPI number? ▼
Does Douglas Gladstone, M.D. prescribe more brand-name or generic drugs? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does Douglas Gladstone, M.D. prescribe most often? ▼
Does Douglas Gladstone, M.D. accept Medicare? ▼
How can I verify Douglas Gladstone, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.